Digital Technology for Diabetes

The use of tissue continuous glucose monitoring (CGM) has increased exponentially the last five years. In the Norwegian diabetes registries 96% of children and 87% of adults with type 1 diabetes in Norway use this technology. The New England Journal ogf Medicine recently had a review article on diabetes technology. This paper was commented in a Letter to the NEJM by professor Tore Julsrud Berg stating the lack of proven clinical effects of the use of CGM in both type 1 and type 2 diabetes. Read the Letter and the authors response here.